Senate Confirms Trump’s Former Surgeon General as New CDC Director

Erica Schwartz, MD, was introduced Wednesday as the CDC’s newest director, according to NBC News.¹ With reports claiming Schwartz as a “conventional” pick for the role, her success will seemingly be judged by her handling of public health challenges, including record highs in measles cases, an ongoing cyclosporiasis outbreak, and the looming respiratory virus season.

“Erica graduated from Brown University for College and Medical School, and served a distinguished career as a Doctor of Medicine in the United States Military, the Greatest and Most Powerful Force in the World, and then served as my Deputy Surgeon General during my First Term,” said President Trump upon his nomination of Schwartz back in April, according to NPR.² “She is a STAR!”

Schwartz, a retired rear admiral in the US Public Health Service Commissioned Corps and a board-certified preventive medicine physician, brings a resume heavy on readiness and preventive care to an agency that has been without a confirmed leader for nearly a year. Her career has spanned service as a Navy physician and chief medical officer in the Coast Guard, suggesting a professional background that some staff hope will restore order to an agency recently beset by infighting among political appointees.^1,2

Her confirmation follows a period of significant leadership turnover; she succeeds interim leader Jay Bhattacharya, who has helmed the agency since February, and takes the mantle following the brief 29-day tenure of Susan Monarez.¹

READ MORE: Most Americans Unaware of CDC's Pregnancy Vaccine Recommendations

Schwartz enters the role with the backing of public health advocacy groups like the American Public Health Association, which cited her track record of competence as both a physician and a manager.²

However, the agency Schwartz inherits is currently defined by institutional turmoil and a staff demoralized by massive personnel and budget cuts.

House Appropriations Ranking Member Rosa DeLauro has warned of the “fatal consequences” of recent staffing reductions, including the reported firing of nearly half the staff of the CDC Epidemic Intelligence Service. DeLauro emphasized that such gutting of the workforce leaves Americans more exposed to the spread of infectious diseases, potentially reversing decades of progress in eradicating illnesses like polio.³

This workforce serves as the primary source of technical assistance and accountability for public health programs at the state and local levels, many of which receive the majority of their funding directly from the CDC.

For pharmacists, the immediate impact of this institutional instability is visible on the clinical front lines. The US is currently grappling with a measles crisis that has seen cases surpass 2100 in the first half of 2026, marking a 35-year high and directly threatening the nation’s elimination status.^1,4

Pharmacists are serving as critical immunization providers as kindergarten MMR vaccination coverage has eroded from 95.2% to 92.5%, falling below the 95% threshold required for community immunity. In states like Utah and Texas, where subregional coverage has dropped as low as 50%, pharmacists are navigating both explosive outbreaks and a rising tide of vaccine hesitancy.⁴

This hesitancy is further complicated by a dramatic collapse in public confidence. A recent poll revealed that trust in the CDC has plummeted to 50%, down from 77% just one year prior.⁵

This decline is sharply polarized along partisan lines, with 68% of respondents expressing concern that health recommendations are too influenced by the personal beliefs of political leaders. Navigating this climate of skepticism places a unique communication burden on pharmacy professionals.

Experts now recommend that pharmacists utilize motivational interviewing techniques, such as open-ended questions and reflections, to build rapport with patients who have encountered widespread misinformation regarding vaccine safety. Lauren Angelo, PharmD, has noted that trust must be earned through persistent community presence and accessibility, particularly as some federal health messaging has become a point of contention.⁴

Schwartz’s relationship with her superior, Health and Human Services Secretary Robert F. Kennedy Jr, will be closely watched by the medical community. During her Senate hearing, Schwartz pledged that her “sacred responsibility” was to provide honest, evidence-based guidance and stated she would “never betray the science.”¹

Yet, she faced criticism for failing to challenge some of Kennedy’s more controversial stances, including recent modifications to CDC webpages regarding vaccines and autism that ignored decades of research showing no association.

The challenges ahead are underscored by a history of political interference in government science. Reports have tracked numerous past instances where public health guidance was manipulated, ranging from the sidelining of scientists to the politicization of testing protocols and the suppression of data in the Morbidity and Mortality Weekly Report.⁶

As Schwartz begins her permanent tenure, the pharmacy profession will look to her to restore the gold standard of science at the CDC while managing immediate threats like the ongoing cyclosporiasis outbreak and the upcoming flu season.^1,2

“We need a CDC director that will actually stand up to crazy, stupid things being said that undermine faith in immunization,” concluded Senator Bill Cassidy (R-Louisiana), according to NBC News.¹ “I am confident that she knows what she is doing and will stand against those who do not.”

READ MORE: CDC Will Focus on BA.2.3 COVID-19 Variant for Upcoming Respiratory Season

REFERENCES

1. Bendix A. New CDC director is confirmed, giving agency its first permanent leader in a year. NBC News. August 5, 2026. Accessed August 5, 2026. https://www.nbcnews.com/health/health-news/new-cdc-director-confirmed-erica-shwartz-rcna590994

2. Huang P. Trump nominates former Coast Guard doctor as CDC chief. NPR. April 16, 2026. Accessed August 5, 2026. https://www.npr.org/2026/04/16/nx-s1-5787959/erica-schwartz-cdc-leadership-nomination

3. Trump Administration’s gutting of CDC will leave Americans sicker and more vulnerable to deadly diseases. News Release. House Committee on Appropriations. February 16, 2025. Accessed August 5, 2026. https://democrats-appropriations.house.gov/news/press-releases/delauro-trump-administrations-gutting-cdc-will-leave-americans-sicker-and-more

4. Gallagher A. Measles cases surpass 2000 in 2026, threatening US elimination status. Drug Topics. June 30, 2026. Accessed August 5, 2026. https://www.drugtopics.com/view/measles-cases-surpass-2000-in-2026-threatening-us-elimination-status

5. Thompson D. Trust in CDC plummets under Trump Administration, new poll shows. US News & World Report. June 15, 2026. Accessed August 5, 2026. https://www.usnews.com/news/health-news/articles/2026-06-15/trust-in-cdc-plummets-under-trump-administration-new-poll-shows

6. Kinsella M, Fowler G, Boland J, et al. Trump Administration abuses thwart US pandemic response. Brennan Center for Justice. July 26, 2021. Accessed August 5, 2026. https://www.brennancenter.org/our-work/research-reports/trump-administration-abuses-thwart-us-pandemic-response